Cognition Therapeutics Inc (CGTX) stock
CGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.63−0.01 (-1.39%)
Close on Nov 17, 2026Market cap $59.90MP/E –Yield –
Cognition Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cognition Therapeutics's enterprise value was $30.37M on Nov 11, 2026, against $114.25M a year earlier. Over the last 5 years it ranged from -$9.74M to $147.12M, with a median of $10.04M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $30.37M | -62.0% |
| 2025 | Dec 31, 2025 | $79.83M | +1108.4% |
| 2024 | Dec 31, 2024 | $6.61M | -71.6% |
| 2023 | Dec 29, 2023 | $23.30M | +525.4% |
| 2022 | Dec 30, 2022 | $3.73M | – |
| 2021 | Dec 31, 2021 | -$4.42M | – |
See a number that looks wrong?